Official product label reference

Lidomar — Oncora Pharma, LLC

This page contains 8 source sections for LIDOMAR, topical route. Label set 215bfdca-60bf-480b-b02e-902de52fe5e8, version 3.

Retrieved 2026-10-02 · openFDA dataset updated 2026-10-02 · Check the current DailyMed label

Label records can cover multiple strengths or package sizes. A label listing does not by itself establish FDA approval or current market availability. Check the source and application history for this specific product.

Uses described in the label

Use(s) For the temporary relief of pain and itching associated with: minor burns sunburn minor cuts scrapes insect bites minor skin irritations rashes due to poison ivy rashes due to poison oak rashes due to poison sumac

Purpose

Purpose Topical analgesic — for temporary relief of minor pain and itching.

Dosage and administration — label text

Directions Apply to the affected area 3 to 4 times daily or as directed by a healthcare provider.

Warnings

Warnings For external use only. Do not use if you are allergic to lidocaine or any of the ingredients. Avoid contact with eyes. Keep out of reach of children. Keep out of reach of childen

Active ingredient

Active ingredient(s) Lidocaine HCl 3%

Child safety

Keep out of reach of childen

Storage and handling

Storage Store at 25°C (77°F); excursions permitted to 15°C–30°C (59°F–86°F). [See USP Controlled Room Temperature]. Keep out of reach of children.

Inactive ingredient

Inactive ingredients Water, cetyl alcohol, glyceryl stearate, PEG-75 stearate, ceteth-20, steareth-20, cyclopentasiloxane, dimethicone, capric/capryl triglyceride, Prunus amygdalus dulcis (sweet almond) oil, stearyl alcohol, phenoxyethanol, ethylhexylglycerin, sodium hydroxide, lactic acid.

Official sources and product identifiers

DailyMed — complete source labelVerify the current version and original formatting, including tables and diagrams.
openFDA — structured source recordMachine-readable label source, linked by the exact label set ID.

Substances listed: LIDOCAINE

Package NDC codes

85477-326-07

Further research and background

These are external searches for related information. Research, encyclopedia and news articles have not been imported into this product record.

Coverage and corrections

The text is extracted from a US structured product label. Tables are represented as text where supplied; formatting and illustrations may be lost. A missing section does not mean a risk is absent. This reference has not been independently reviewed by a clinician and is not a live safety-alert service.

Source retrieved 2026-10-02. Read the source policy.

Lidomar drug information